ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,321.49
0.34%
Dow Jones
40,050.38
0.12%
US Dollar vs MXN
16.58845
-0.08%
Brent Oil
83.52
-0.09%
Bitcoin
67,310.00
1.74%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. YS Biopharma Company Ltd (YS)

  7. YS Biopharma Company Ltd (YS) Noticias

YS

YS Biopharma (YS)

YS Biopharma Company Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:YS
FechaHoraFuenteTítuloSímboloCompañía
07/05/202415:20PR Newswire (US)YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive OfficerNASDAQ:YSYS Biopharma Company Ltd
29/04/202407:00PR Newswire (US)YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price RuleNASDAQ:YSYS Biopharma Company Ltd
19/04/202406:00PR Newswire (US)YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024NASDAQ:YSYS Biopharma Company Ltd
18/04/202407:00PR Newswire (US)YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus VaccineNASDAQ:YSYS Biopharma Company Ltd
16/04/202407:00PR Newswire (US)YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024NASDAQ:YSYS Biopharma Company Ltd
09/04/202407:00PR Newswire (US)YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies VaccineNASDAQ:YSYS Biopharma Company Ltd
03/04/202407:00PR Newswire (US)YS Biopharma Announces Full Repayment of US$40,000,000 Loan FacilityNASDAQ:YSYS Biopharma Company Ltd
05/03/202407:00PR Newswire (US)YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese SubsidiariesNASDAQ:YSYS Biopharma Company Ltd
22/02/202416:00PR Newswire (US)YS Biopharma Announces Results of Extraordinary General Meeting held on February 22, 2024NASDAQ:YSYS Biopharma Company Ltd
18/02/202403:30PR Newswire (US)/C O R R E C T I O N -- YS Biopharma Co., Ltd./NASDAQ:YSYS Biopharma Company Ltd
16/02/202419:20PR Newswire (US)YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the MeetingNASDAQ:YSYS Biopharma Company Ltd
14/02/202407:00PR Newswire (US)YS Biopharma to Hold an Extraordinary General Meeting on February 22, 2024 pursuant to a Shareholder Requisition to Enhance Corporate GovernanceNASDAQ:YSYS Biopharma Company Ltd
14/02/202406:50PR Newswire (US)YS Biopharma Announces Appointment of New DirectorsNASDAQ:YSYS Biopharma Company Ltd
12/02/202407:50PR Newswire (US)YS Biopharma Responds to a Notice of Extraordinary General Meeting of Shareholders of YS Biopharma Co., Ltd.NASDAQ:YSYS Biopharma Company Ltd
09/02/202405:30PR Newswire (US)YS Biopharma Announces US$40 Million Private Placement FinancingNASDAQ:YSYS Biopharma Company Ltd
08/02/202417:10PR Newswire (US)Shareholders of YS Biopharma Announce an Extraordinary General MeetingNASDAQ:YSYS Biopharma Company Ltd
22/01/202416:00PR Newswire (US)YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024NASDAQ:YSYS Biopharma Company Ltd
08/01/202407:00PR Newswire (US)YS Biopharma Announces Changes to its Board CommitteesNASDAQ:YSYS Biopharma Company Ltd
20/12/202315:30PR Newswire (US)YS Biopharma Responds to Unauthorized Press Release Regarding Extraordinary General MeetingNASDAQ:YSYS Biopharma Company Ltd
20/12/202307:56PR Newswire (US)YS Biopharma Co., Ltd. to Hold Extraordinary General Meeting on December 28, 2023NASDAQ:YSYS Biopharma Company Ltd
14/11/202307:30PR Newswire (US)Noble Capital Markets Initiates Coverage on YS Biopharma With Outperform Rating and US$5.25 Price TargetNASDAQ:YSYS Biopharma Company Ltd
31/10/202307:30PR Newswire (US)YS Biopharma Announces Completion of Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies VaccineNASDAQ:YSYS Biopharma Company Ltd
26/10/202307:30PR Newswire (US)YS Biopharma Announces Receipt of Nasdaq NoticeNASDAQ:YSYS Biopharma Company Ltd
26/09/202307:30PR Newswire (US)YS Biopharma Announces First Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies VaccineNASDAQ:YSYS Biopharma Company Ltd
15/09/202307:30PR Newswire (US)YS Biopharma Granted Patent in the U.S. for Immunotherapy Targeting Chronic Hepatitis B Virus InfectionNASDAQ:YSYS Biopharma Company Ltd
05/09/202307:30PR Newswire (US)YS Biopharma to Participate in Participate in Citi's 18th Annual Biopharma ConferenceNASDAQ:YSYS Biopharma Company Ltd
24/08/202315:15PR Newswire (US)YS Biopharma Announces Purchase of Shares by Company OfficersNASDAQ:YSYS Biopharma Company Ltd
15/08/202316:00PR Newswire (US)YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024NASDAQ:YSYS Biopharma Company Ltd
26/07/202316:00PR Newswire (US)YS Biopharma Announces Financial Results for Fiscal Year 2023 Ended March 31, 2023NASDAQ:YSYS Biopharma Company Ltd
21/07/202315:30PR Newswire (US)YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023NASDAQ:YSYS Biopharma Company Ltd
 Showing the most relevant articles for your search:NASDAQ:YS

Su Consulta Reciente

TG
A28URV
Luminor Bank
TIDE
SVDBTC
TG
A2R2MA
AT & T
BOV
DISB34
TWDC Enterprises 18
TG
ALVC
Allianz
BOV
PYPL34
PayPal
BIT
P210M5
NLBNPIT210M5 20991231 87...
TG
A19KJY
Regie Autonome des Trans...
BIT
P1WSS9
NLBNPIT1WSS9 20250620 33...
COIN
TOKENEUR
CSE
QREE
Quebec Rare Earth Elements
TG
A3K2AQ
Alfa Laval Holding AB
TG
AF9N
Agence Francaise de Deve...
NASDAQ
CUNO
Cuno
TSX
GUTB.U
Guardian Ultra Short US ...
SOTX
OMEGABTC
OmegaCoin
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados